08-Apr-2022 Redx Presents Encouraging RXC004 Preclinical Data at the AACR Annual Meeting in Combination with Clinically Relevant Standard of Care Regimens
05-Apr-2022 Redx Announces Collaboration with the Garvan Institute of Medical Research
ILD Summit Presentation: Selective Inhibition of ROCK2 – Promising Approach to Target Fibrosis 9 March 2022
Redx Corporate Presentation
30-Mar-2022 New Trinity Delta Research Report – RXC008 nominated as GI-ROCK drug candidate
17-Feb-2022 New Trinity Delta Research Report – Building on an impressive track-record
27-Jan-2022 New Trinity Delta Research Report – FY21 results: a year of continuing delivery
12-Oct-2021 Trinity Delta – R&D update: RXC004 and RXC007 in the spotlight
1. Where is the Company’s registered office?
Block 33, Mereside, Alderley Park, Macclesfield SK10 4TG
2. How can I contact the company?
Please email us at firstname.lastname@example.org
3. What is the Company’s financial year end?
Our financial year ends on 30 September
4. Are the company’s shares listed?
Yes, our shares are listed on the AIM market. Operated by the London Stock Exchange.
5. How can I stay up to date with Company news?
Our website is updated frequently, and you can register for email alerts from within the investors section of our website.